Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.

@article{Rowbotham2004VenlafaxineER,
  title={Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.},
  author={Michael C. Rowbotham and Veeraindar Goli and Nadia R Kunz and Dean Lei},
  journal={Pain},
  year={2004},
  volume={110 3},
  pages={697-706}
}
To evaluate the efficacy and safety of 6 weeks of venlafaxine extended-release (ER) (75 mg and 150-225 mg) treatment in patients with painful diabetic neuropathy. This multicenter, double-blind, randomized, placebo-controlled study included 244 adult outpatients with metabolically stable type 1 or 2 diabetes with painful diabetic neuropathy. Primary efficacy measures were scores on the daily 100 mm Visual Analog Pain Intensity (VAS-PI) and Pain Relief (VAS-PR) scales. Secondary efficacy… CONTINUE READING
125 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 125 extracted citations

Similar Papers

Loading similar papers…